🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Pitfalls of p63: Case 5 This one is for the history books. What is your diagnosis? Again, diagnosis and explanation for both today's and yesterday's cases on Monday. Have a great weekend and see you next week! WashU Medicine Pathology & Immunology WashU Medicine Pathology & Immunology Education #breastpath #PathTwitter #PathX

Spiritual Sunday One of the reasons many people struggle with eastern spiritual teachings and philosophy is the frequent confluence of the “I” in the language used to describe the self in its different manifestations. “I” am mortal and “I” am immortal, “I” am one with all and

Happy Monday everyone! Let's go over case 4 of last week's series of p63 pitfalls. Tomorrow, we will tackle case 5. The diagnosis in this case is adenoid cystic carcinoma (ACC), tubular variant, which lacks the classic cribriform architecture of ACC and instead shows small

Time for the last case (case 5) of last week's series of p63 pitfalls. I might include one more in the coming days just for fun. In this case, we have a proliferation of malignant cells in anastomosing ducts with a desmoplastic response, invasive by H&E in my opinion, but with a

Here's the bonus case addressing p63 pitfalls. This scenario has been discussed before and it is quite controversial with no hard evidence to support either viewpoint. I do know where I stand on the matter though. Images show H&E, p63 and CK5/6. What is your diagnosis?

One last case before a long-winded discussion of the in-situ vs. invasive dilemma in the absence of positivity for myoepithelial markers. Images show H&E, p63 (apologies about the weak counterstain), and SMM. What is your diagnosis? WashU Medicine Pathology & Immunology WashU Medicine Pathology & Immunology Education #breastpath

Our posters at #USCAP2025 with Reza Taha, MD and Ana Villanueva Great work you guys. #PathTwitter #breastpath WashU Medicine Pathology & Immunology WashU Medicine Pathology & Immunology Education

“You yourself will always be the worst enemy you can encounter; you yourself lie in wait for yourself in caves and forests.” - Friedrich Nietzsche When we are our own enemy, when the greatest obstacle standing in the way of our dreams is our own self, the challenge seems

Here's a question to the #PathTwitter and #breastpath community. If you have two partial mastectomies from the same breast, both with IDC and DCIS, and an ipsilateral sentinel lymph node biopsy, how many synoptic reports do you include? one? two? Why?

Been silent for a while, so here's one of my favorite things to talk about. What is your diagnosis? UDH? ADH? DCIS? #breastpath #PathTwitter WashU Medicine Pathology & Immunology WashU Medicine Pathology & Immunology Education

Latest publication. Thank you Reza Taha, MD and Appl Immunohistochem Mol Morphol Journal !

Invasive solid papillary carcinoma with mucin production #breastpath